A.R.T. Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-21,541
| Closed | -$48K | – | 231 |
|
|
2019
Q4 | $48K | Buy |
21,541
+1,800
| +9% | +$4.01K | ﹤0.01% | 1250 |
|
|
2019
Q3 | $42K | Sell |
19,741
-33,000
| -63% | -$70.2K | ﹤0.01% | 1328 |
|
|
2019
Q2 | $141K | Buy |
52,741
+21,741
| +70% | +$58.1K | 0.01% | 1154 |
|
|
2019
Q1 | $153K | Buy |
+31,000
| New | +$153K | 0.01% | 1115 |
|
|
2018
Q2 | – | Sell |
-7,477
| Closed | -$261K | – | 1464 |
|
|
2018
Q1 | $261K | Buy |
7,477
+2,187
| +41% | +$76.3K | 0.01% | 1181 |
|
|
2017
Q4 | $225K | Sell |
5,290
-382
| -7% | -$16.2K | 0.01% | 1123 |
|
|
2017
Q3 | $243K | Buy |
+5,672
| New | +$243K | 0.01% | 1080 |
|
|
2017
Q2 | – | Sell |
-7,160
| Closed | -$387K | – | 1447 |
|
|
2017
Q1 | $387K | Sell |
7,160
-3,713
| -34% | -$201K | 0.02% | 901 |
|
|
2016
Q4 | $577K | Buy |
10,873
+9,826
| +938% | +$521K | 0.03% | 685 |
|
|
2016
Q3 | $63K | Sell |
1,047
-31,207
| -97% | -$1.88M | 0.02% | 585 |
|
|
2016
Q2 | $2.12M | Sell |
32,254
-28,534
| -47% | -$1.88M | 0.11% | 295 |
|
|
2016
Q1 | $3.45M | Buy |
+60,788
| New | +$3.45M | 0.15% | 183 |
|
|
2015
Q2 | – | Sell |
-597
| Closed | -$249K | – | 1499 |
|
|
2015
Q1 | $249K | Buy |
+597
| New | +$249K | 0.01% | 1166 |
|
|
2014
Q2 | – | Sell |
-5,729
| Closed | -$1.52M | – | 1324 |
|
|
2014
Q1 | $1.52M | Buy |
5,729
+3,580
| +167% | +$949K | 0.08% | 345 |
|
|
2013
Q4 | $780K | Buy |
+2,149
| New | +$780K | 0.04% | 591 |
|
|
2013
Q3 | – | Sell |
-4,060
| Closed | -$950K | – | 1324 |
|
|
2013
Q2 | $950K | Buy |
+4,060
| New | +$950K | 0.03% | 650 |
|